Rasmus Holm-Jorgensen insider trades

Open-market stock purchases and sales by Rasmus Holm-Jorgensen, Chief Financial Officer at Acrivon Therapeutics, Inc, from SEC Form 4 filings since Nov 14, 2022.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ACRV Acrivon Therapeutics, Inc: other filings, last Mar 1, 2025

Get free alerts when Rasmus Holm-Jorgensen files a new trade →